These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23122871

  • 1. Oxyntomodulin attenuates exendin-4-induced hypoglycemia in cattle.
    ThanThan S, Asada Y, Saito T, Ochiiwa K, Zhao H, Yannaing S, Kuwayama H.
    Domest Anim Endocrinol; 2013 Feb; 44(2):70-80. PubMed ID: 23122871
    [Abstract] [Full Text] [Related]

  • 2. Oxyntomodulin analog and exendin-4 derivative lower plasma glucose in cattle.
    ThanThan S, Asada Y, Saito T, Ochiiwa K, Zhao H, Naing SW, Kuwayama H.
    Domest Anim Endocrinol; 2017 Apr; 59():30-36. PubMed ID: 27888738
    [Abstract] [Full Text] [Related]

  • 3. Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle.
    ThanThan S, Saito T, Yannaing S, Zhao H, Nakashima K, Kuwayama H.
    Domest Anim Endocrinol; 2012 Apr; 42(3):155-64. PubMed ID: 22154917
    [Abstract] [Full Text] [Related]

  • 4. Oxyntomodulin increases the concentrations of insulin and glucose in plasma but does not affect ghrelin secretion in Holstein cattle under normal physiological conditions.
    ThanThan S, Zhao H, Yannaing S, Ishikawa T, Kuwayama H.
    Domest Anim Endocrinol; 2010 Oct; 39(3):163-70. PubMed ID: 20705414
    [Abstract] [Full Text] [Related]

  • 5. Plasma concentrations and effects of glucagon-like peptide-1 (7-36) amide in calves before and after weaning.
    Fukumori R, Mita T, Sugino T, Obitsu T, Taniguchi K.
    Domest Anim Endocrinol; 2012 Nov; 43(4):299-306. PubMed ID: 22683323
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
    Du X, Kosinski JR, Lao J, Shen X, Petrov A, Chicchi GG, Eiermann GJ, Pocai A.
    Am J Physiol Endocrinol Metab; 2012 Jul 15; 303(2):E265-71. PubMed ID: 22621866
    [Abstract] [Full Text] [Related]

  • 7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Gastroenterology; 2004 Aug 15; 127(2):546-58. PubMed ID: 15300587
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.
    Diabetologia; 2002 Oct 15; 45(10):1410-5. PubMed ID: 12378382
    [Abstract] [Full Text] [Related]

  • 9. Intracerebroventricular administration of chicken oxyntomodulin suppresses food intake and increases plasma glucose and corticosterone concentrations in chicks.
    Honda K, Saneyasu T, Yamaguchi T, Shimatani T, Aoki K, Nakanishi K, Kamisoyama H.
    Neurosci Lett; 2014 Apr 03; 564():57-61. PubMed ID: 24530259
    [Abstract] [Full Text] [Related]

  • 10. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
    Bhat VK, Kerr BD, Flatt PR, Gault VA.
    Biochem Pharmacol; 2013 Jun 01; 85(11):1655-62. PubMed ID: 23518155
    [Abstract] [Full Text] [Related]

  • 11. Sulfated cholecystokinin-8 increases ghrelin secretion but does not affect oxyntomodulin in Holstein steers.
    Yannaing S, Thidarmyint H, Zhao H, Thanthan S, Kitagawa K, Kuwayama H.
    Anim Sci J; 2012 Aug 01; 83(8):577-84. PubMed ID: 22862927
    [Abstract] [Full Text] [Related]

  • 12. Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus.
    Lynch AM, Pathak N, Flatt YE, Gault VA, O'Harte FP, Irwin N, Flatt PR.
    Eur J Pharmacol; 2014 Nov 15; 743():69-78. PubMed ID: 25246014
    [Abstract] [Full Text] [Related]

  • 13. Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals.
    Malendowicz LK, Nowak KW.
    Int J Mol Med; 2002 Sep 15; 10(3):327-31. PubMed ID: 12165809
    [Abstract] [Full Text] [Related]

  • 14. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
    Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR.
    Endocrinology; 2004 Jun 15; 145(6):2687-95. PubMed ID: 15001546
    [Abstract] [Full Text] [Related]

  • 15. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A, Lovshin JA, Baggio LL, Drucker DJ.
    Endocrinology; 2008 Nov 15; 149(11):5670-8. PubMed ID: 18669601
    [Abstract] [Full Text] [Related]

  • 16. Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.
    Shankar SS, Shankar RR, Mixson LA, Miller DL, Pramanik B, O'Dowd AK, Williams DM, Frederick CB, Beals CR, Stoch SA, Steinberg HO, Kelley DE.
    Diabetes; 2018 Jun 15; 67(6):1105-1112. PubMed ID: 29545266
    [Abstract] [Full Text] [Related]

  • 17. (D-Ser2)Oxm[mPEG-PAL]: a novel chemically modified analogue of oxyntomodulin with antihyperglycaemic, insulinotropic and anorexigenic actions.
    Kerr BD, Flatt PR, Gault VA.
    Biochem Pharmacol; 2010 Dec 01; 80(11):1727-35. PubMed ID: 20735990
    [Abstract] [Full Text] [Related]

  • 18. Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.
    Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP.
    Am J Physiol Endocrinol Metab; 2008 Jan 01; 294(1):E142-7. PubMed ID: 17971509
    [Abstract] [Full Text] [Related]

  • 19. Effects of glucagon-like peptide 1 and oxyntomodulin on neuronal activity of ghrelin-sensitive neurons in the hypothalamic arcuate nucleus.
    Riediger T, Eisele N, Scheel C, Lutz TA.
    Am J Physiol Regul Integr Comp Physiol; 2010 Apr 01; 298(4):R1061-7. PubMed ID: 20147608
    [Abstract] [Full Text] [Related]

  • 20. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM, Kendall ES, Reynolds JM, Lwin AN, Herich JP, Smith PA, Gedulin BR, Flanagan SD, Jodka CM, Hoyt JA, McCowen KM, Parkes DG, Anderson CM.
    Regul Pept; 2007 Jun 07; 141(1-3):113-9. PubMed ID: 17292977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.